In pancreatic ductal adenocarcinoma, TSPAN7 inhibits RAD51AP1‐mediated DSB repair, activating cGAS‐STING signalling to increase CD8+ T‐cell infiltration and improve chemoimmunotherapy efficacy [53]. Here, TSPAN7 is linked to pancreatic ductal adenocarcinoma.